Lymphocyte Migration and Retention Properties Affected by Ibrutinib in Chronic Lymphocytic Leukemia

To explore the mechanism of action of ibrutinib and its potential impact on non-leukemic cells, investigators quantified multiple motility and adhesion parameters of human primary chronic lymphocytic leukemia cells and non-leukemic lymphoid cells.